Poolbeg Pharma (POLB), a biopharmaceutical company, announces that, further to its announcement in July 2022, it has now received the initial results having completed the Lipopolysaccharide human challenge clinical trial for POLB 001, a viral strain agnostic, small molecule immunomodulator being developed to address the unmet medical need for severe influenza.
Rockfire Resources (ROCK), the gold, base metal and critical mineral exploration company, announced that inaugural drilling has encountered massive sulphides at the predicted depth and position at its 100%-owned Molaoi zinc/silver/lead/germanium deposit in Greece. The company said this drilling is providing important geotechnical information for its team.
It is always good to quit while you are ahead. CentralNic Group (CNIC), the internet software company, announce the appointment of Michael Riedl, currently Group CFO, as Group CEO with immediate effect. Michael succeeds Ben Crawford, who retires from the board today.
Oriole Resources (ORR), the AIM-quoted gold exploration company, reported a maiden Inferred JORC-compliant Mineral Resource Estimate of 305,000 Troy ounces grading 2.19 grammes per tonne gold for Bakassi Zone 1, one of four prospects at its 90%-owned Bibemi orogenic gold project in Cameroon.
There is more significant contract news for Kromek Group (KMK), a developer of radiation and bio-detection technology solutions. The company announced that it has secured two contracts, totalling £1.5m, for the supply of its D3M and D3S-based nuclear security products. The company said delivery will commence immediately and the revenue will be received in Kromek’s current financial year.
Block Energy (BLOE), the exploration and production company focused on Georgia, announced that binding documentation has been entered into with Georgia Oil and Gas Limited with respect to a farm-out of part of the Company’s XIB licence. The farmout terms amount to a work programme with an estimated value of USD 3.0 million comprising $2.5 million for a 2D seismic acquisition and USD 0.5 million for seismic reprocessing
Savannah Energy (SAVE), the British independent energy company, announce that it has entered into a Share Purchase Agreement with PETRONAS to acquire PETRONAS’ entire oil and gas business in South Sudan through the acquisition of Petronas Carigali Nile Limited, for a total cash consideration of up to $1.25 billion, subject to certain completion adjustments.
Kibo Energy (KIBO), announced at 7.30am, that its shares have been temporarily suspended.
It would appear that the correct leads have now been plugged into the correct sockets. Aquis Exchange (AQX), the exchange services group, announced that the most popular AQSE stocks are now available to trade electronically on IG Group’s platform, IG.com.
Totally (TLY), a provider of frontline healthcare services, announced the acquisition of the entire issued share capital of Pioneer Health Care Limited, an established independent provider of specialist NHS secondary care services. The maximum total consideration for the Acquisition is £13.0 million.
Hemogenyx Pharmaceuticals (HEMO), the biopharmaceutical group, announced the completion of its first Process Qualification run of the end-to-end process for the manufacture of HEMO-CAR-T cells. The company said this PQ run is one of a minimum of three identical manufacturing runs required for the submission of the Investigational New Drug application to the FDA.
MJ Hudson (MJH) announced that it was engaged in discussions with its auditors regarding significant potential adjustments in relation to the year-end reporting for FY 2022. This work continues but the Board has become aware of additional issues, including in relation to the reporting of historical trading of the business in relation to FY 2022, the full impact of which is unclear. Pending clarification of these matters, the Group has applied to suspend trading of the Company’s ordinary shares on AIM, which will be effective before 08.00 a.m. today.
Capital Metals (CMET), a natural resources company, announced that notice has been provided by the Geological Survey and Mines Bureau to the company’s Sri Lankan subsidiary Damsila Exports Pvt Limited that they consider it necessary for the current shareholding structure of Damsila to have been approved by the Board of Investment of Sri Lanka and as Damsila has not obtained such approval they will be carrying out proper investigations regarding the ownership structure of Damsila, and that in the meantime the two Industrial Mining Licences which were issued to Damsila are temporarily suspended.
Velocys (VLS), the sustainable fuels technology company, announces that in addition to the £27m grant from the UK Department for Transport’s Advanced Fuels Fund for the Altalto waste-to-SAF project. It has also been awarded a grant of £2.5 million from the same fund, to contribute its technology to an e-fuels project in the UK in collaboration with a number of new and existing partners.
ANGLE (AGL), a liquid biopsy company, announced the presentation of two posters at the San Antonio Breast Cancer Symposium, in San Antonio, Texas, United States, between 06-10 December 2022. The studies demonstrated the successful isolation and subsequent analysis of circulating tumour cells from Metastatic Breast Cancer patient blood samples using the Parsortix® PC1 Clinical System.
Advanced Oncotherapy (AVO), the developer of LIGHT, the proton therapy system for cancer treatment, announced an equity fundraise of £1.5m before expenses. The fundraise has been conducted through a direct subscription with the company 25p. The Subscription Shares have been subscribed for by an existing institutional shareholder.
First Class Metals (FCM) the UK metals exploration company seeking large scale metal discoveries across its extensive Canadian Schreiber-Hemlo & Sunbeam land holding, announced that it has entered into an exclusivity agreement with a third party in respect to a Lithium project in Ontario. FCM also completed a premium fundraising from a private subscription of £300,000 to one single HNW resource sector investor at 16p per share.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
